Westlake Corporation (WLK)

NYSE Materials Specialty Chemicals S&P MidCap 400
$63.49
-2.79 (-4.21%)
Close of Nov 06, 2026 · end-of-day data

WLK 8-K filings in 2025

Every material Form 8-K Westlake filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2025616 on record in all
Latest filing in 2025Dec 15, 2025restructuring
High impact (4-5)5of 6 briefs
ToneNegative4Mixed1Neutral1
earnings 3restructuring 2financing 1
Dec 15, 7:30 AM ET

Westlake to close North American chlorovinyl units and styrene plant, $415 million charge

Mixed restructuring Written later 2.057.01

Westlake approved plans to shut its PVC plant in Aberdeen, Mississippi, a VCM plant and one chlor-alkali unit in Lake Charles, Louisiana, and its styrene plant in Lake Charles, with cessations expected in December 2025 and about 295 jobs affected. The company expects total pre-tax costs of about $415 million, mostly noncash charges, with a substantial portion recognized in the fourth quarter of 2025, which will weigh on reported results even as the company projects lower annual costs and higher cash flow from 2026.

  • Cessation of operations expected in December 2025; workforce reduction of about 295 employees.
  • Total pre-tax costs of about $415 million: about $357 million noncash, about $25 million severance, and about $33 million plant shutdown costs.
  • Investor slides expect an annual EBITDA improvement of about $100 million and free cash flow savings of about $175 million in 2026.
  • Company says cash outflows will continue over several years and may disclose additional charges later.
Read the filing on SEC.gov ↗
Nov 5, 5:03 PM ET

Westlake prices $1.2 billion senior notes offering due 2035 and 2055

Neutral financing Written later 1.017.01

Westlake Corporation agreed to sell $600 million of 5.550% senior notes due 2035 and $600 million of 6.375% senior notes due 2055, with closing expected November 6, 2025. The company expects net proceeds of about $1.185 billion, which it plans to use mainly to repurchase its $750 million of 3.600% senior notes due 2026, with any remainder going to the pending ACI Acquisition and general corporate purposes.

  • Two tranches total $1.2 billion: $600 million of 5.550% notes due November 15, 2035 and $600 million of 6.375% notes due November 15, 2055
  • Expected net proceeds of approximately $1.185 billion before offering expenses
  • Proceeds intended first to fund a concurrent tender offer for the $750 million of 3.600% senior notes due 2026 outstanding as of September 30, 2025
  • Remaining proceeds may fund the pending ACI/Perplastic Group compounding solutions acquisition and general corporate purposes
Read the filing on SEC.gov ↗
Oct 30, 7:33 AM ET

Westlake posts $782 million Q3 net loss on $727 million chlorovinyls goodwill impairment

Negative earnings Written later 2.027.01

Westlake reported a third-quarter 2025 net loss of $782 million, or $6.06 per share, including a non-cash $727 million charge to write off all goodwill tied to its North American Chlorovinyls unit. Excluding identified items, the net loss was $38 million, or $0.29 per share, compared with net income of $108 million, or $0.83 per share, a year earlier. Shareholders face weaker sales and profit, and the company says cost savings and a plant shutdown should help margins in 2026.

  • Net sales were $2.8 billion, down from $3.1 billion in the third quarter of 2024.
  • EBITDA excluding identified items was $313 million, compared with $580 million a year earlier.
  • Identified items included the $727 million goodwill impairment and $17 million of accrued shutdown expenses.
  • Management expects about $200 million of cost savings in 2026 and about $100 million of annual losses removed from the Pernis shutdown starting in 2026.
Read the filing on SEC.gov ↗
Aug 5, 7:25 AM ET

Westlake swings to $142 million Q2 net loss on $130 million plant charges

Negative earnings Written later 2.027.01

Westlake reported a second-quarter 2025 net loss of $142 million, or $1.11 per diluted share, compared with net income of $313 million, or $2.40 per share, a year earlier. Net sales fell to $2.95 billion from $3.21 billion, and the results include $130 million of charges tied to closing the Pernis facility in The Netherlands and pausing a PVC unit in China. Excluding these items, the net loss was $12 million, or $0.09 per share, and the company expanded its cost-reduction target to an additional $200 million by 2026.

  • Net sales of $2,953 million in Q2 2025, down from $3,207 million in Q2 2024 but up from $2,846 million in Q1 2025.
  • Net loss of $142 million, or $1.11 per diluted share; excluding $130 million of identified items, net loss was $12 million, or $0.09 per share.
  • EBITDA excluding identified items was $340 million, compared with $744 million in Q2 2024 and $288 million in Q1 2025.
  • Cost-reduction target expanded to an additional $200 million of reductions by 2026, on top of a 2025 target of $150 million to $175 million.
Read the filing on SEC.gov ↗
Jun 17, 6:01 AM ET

Westlake to close Pernis, Netherlands, facility; about EUR 190 million in pre-tax costs

Negative restructuring Written later 2.05

Westlake said it began consultations with works councils on June 13, 2025, over ceasing operations at its entire Pernis, Netherlands, facility in 2025, citing continued deterioration of its European business. The company expects total pre-tax closure costs of about EUR 190 million and a further workforce reduction of about 230 employees, with a charge for substantially all of these costs in the second quarter of 2025. Cash outflows will continue for several years after closure, and the amount and timing of some costs remain uncertain, so shareholders face a large near-term charge and continuing spending.

  • Plan to cease operations at the entire Pernis facility in 2025, subject to consultations with works councils and unions; employees were notified on June 17, 2025.
  • Expected pre-tax costs of about EUR 190 million: about EUR 30 million for employee severance and separation and about EUR 160 million for environmental remediation and plant shutdown.
  • About 230 additional employees expected to be affected by the closure.
  • Charge for substantially all costs expected in the second quarter of 2025; Deer Park, Texas will continue supplying LER and BPA customers.
Read the filing on SEC.gov ↗
May 2, 7:25 AM ET

Westlake swings to $40 million Q1 loss; 2025 HIP outlook set to low end of range

Negative earnings Written later 2.027.01

Westlake reported a first-quarter 2025 net loss of $40 million, or $0.31 per diluted share, on net sales of $2.8 billion, compared with net income of $174 million, or $1.34 per share, a year earlier. EBITDA fell to $288 million from $546 million, driven by higher North American feedstock and energy costs and planned and unplanned plant outages. The company also said 2025 Housing and Infrastructure Products revenue and EBITDA margin are now expected toward the low ends of prior ranges, and it cut its 2025 capital spending target by 10% to $900 million.

  • Q1 2025 net loss of $40 million ($0.31 per diluted share) versus net income of $174 million ($1.34 per share) in Q1 2024
  • EBITDA of $288 million, down from $546 million a year earlier; PEM segment EBITDA was $73 million versus $253 million
  • 2025 HIP revenue expected toward the low end of $4.4 billion to $4.6 billion, and EBITDA margin toward the low end of 20% to 22%
  • 2025 capital spending target reduced 10% to $900 million; cash, equivalents and fixed income investments of $2.5 billion as of March 31, 2025
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Westlake filing is on SEC EDGAR ↗. 8-K briefs of other companies →